Anesth Analg 2000;90:195
© 2000 International Anesthesia Research Society
GENERAL ARTICLES
Strain Differences in the Antinociceptive Effect of Nitrous Oxide on the Tail Flick Test in Rats
Christo Fender, BA*, ,
Masahiko Fujinaga, MD*, , , and
Mervyn Maze, MB, ChB, FRCP, FRCA*, ,
*Department of Anesthesia, Stanford University School of Medicine, Stanford;
Anesthesiology Service, Veterans Administration Palo Alto Health Care System, Palo Alto, California; and
Magill Department of Anaesthetics, Imperial College School of Medicine, Chelsea and Westminster Campus, London, United Kingdom
Address correspondence and reprint requests to Dr. Masahiko Fujinaga, Magill Department of Anaesthetics, Imperial College School of Medicine, Chelsea and Westminster Campus, 369 Fulham Rd., London, SW10 9NH, UK. Address e-mail to m.fujinaga{at}ic.ac.uk
 |
Abstract
|
|---|
To study strain differences in antinociceptive effects of nitrous oxide (N2O), we examined various outbred and inbred stains of rats by using tail flick latency response. All outbred strains, i.e., Sprague-Dawley from two different breeders, Wistar, and Long-Evans, showed a similar antinociceptive response. Namely, the peak response occurred after 30 min of exposure, and tolerance to N2O developed within 60 to 90 min. Each of the four inbred stains examined, i.e., Wistar-Kyoto, Brown-Norway, Fischer, and Lewis, displayed a unique pattern of antinociceptive response to N2O. Wistar-Kyoto and Brown-Norway strains showed somewhat similar patterns as those observed in outbred strains, apart from the fact that the Wistar-Kyoto displayed a more distinct development of tolerance, whereas, the Brown-Norway strain had a lower peak effect. The Fischer strain displayed the greatest antinociceptive response to N2O, and did not develop tolerance. The Lewis strain showed no antinociceptive response to N2O. These results indicate differences in the durability and the magnitude of the antinociceptive response to N2O among various strains of rats.
Implications: Because of the variability that already exists, we recommend that animal studies examining the antinociceptive effects of nitrous oxide should be performed on inbred rat strains.
 |
Introduction
|
|---|
The antinociceptive effect of nitrous oxide (N2O) diminishes over time during continuous administration in humans (1,2). This biologic phenomenon, referred to as "tolerance," has also been demonstrated in rats and mice by using either temperature (37) or pressure (8) as the stimulus for nociception. Tolerance to other neurobehavioral effects of N2O has been reported in cats involving electroencephalogram activity (9) and anticonvulsant action (10). However, Shingu et al. (11) found that tolerance does not develop to analgesic effects of N2O determined in rats by using the tail flick test. Quock et al. (12,13) also found quantitative differences in the antinociceptive response of various mouse strains to N2O using the abdominal constriction test (12,13). This differential sensitivity to N2O among different strains of mice prompted us to study strain differences in antinociceptive effects of N2O on the tail flick test in rats.
 |
Methods
|
|---|
The study protocol was approved by the institutional animal investigation committee (Stanford University and Veterans Adminstration Palo Alto Health Care System). Animals were provided ad libitum food and water and artificial lighting between 6 AM and 6 PM. Adult male rats of four outbred strains, Sprague-Dawley (B & K Universal, Freemont, CA), Sprague-Dawley (Charles-River, Wilmington, MA), Wistar (Charles-River), and Long-Evans (Charles-River), were used along with adult male rats of four inbred strains (all from Charles-River), namely, Wistar-Kyoto, Brown-Norway, Fischer, and Lewis (Table 1). All experiments were performed between 11 AM and 4 PM, and each animal was used for only one set of studies to eliminate the effects of learning and chronic tolerance on tail flick latency (TFL).
The Tail Flick Test
A high-intensity light was focused on the dorsal side of the middle third of the rats tail and the time for the rat to move its tail out of the light beam was recorded (Tail-Flick Analgesia Meter; Columbus Instruments, Columbus, OH) and referred to as TFL. The intensity of heat was set so that basal TFL occurred between 3 and 4 s. A cut off latency of 10 s was arbitrarily selected. TFL was measured to the nearest 0.1 s. Each TFL measurement consisted of a mean of three separate trials over 5 min. This was repeated every 30 min.
Before ascertaining baseline TFL, each rat was placed in a cylindrical plastic restrainer (Broome Rodent Restrainer; Harvard Apparatus, South Natick, MA), which prevented free movement while allowing easy access to the length of the tail. Rats were allowed to accommodate to their restrainers for 2 h before baseline tail flick measurements were taken. All rats were confined to their individual restrainers throughout the duration of the experiment.
N2O Exposure
All gas exposure was performed in a Plexiglas chamber (20 in. long, 35 in. wide, and 15 in. high) with a sliding door on one side (for insertion of animals). This airtight chamber was large enough to enclose the Tail-Flick Analgesia Meter and up to five rats, each in its individual restrainer. Fresh test gases (10 L/min) were delivered from an anesthetic machine into the chamber via an inflow port, circulated throughout the chamber by two small fans, and purged by a vacuum set to aspirate at the same rate as the fresh gas inflow. Gas concentrations, including those for N2O, oxygen (O2),and carbon dioxide (CO2), were monitored continuously by infrared gas spectrometry (Datex 254 airway monitor; Datex Medical Instrument, Tewksbury, MA), and recorded on a strip chart recorder. N2O concentration was maintained between 70% and 75%, while O2 concentration was maintained between 20% and 25%. Male rats of different strains were exposed to either 75% N2O/25% O2 (N2O group) or room air (control group).
The data were expressed as percent of maximal possible effect (%MPE) as follows:
This approach normalizes the distribution of data while retaining the graded analysis (14). Data between control and N2O groups were analyzed by one-way analysis of variance. A P value <0.05 was considered significant.
 |
Results
|
|---|
All outbred strains we examined, i.e., Sprague-Dawley, Sprague-Dawley, Wistar, and Long-Evans, showed a similar antinociceptive response to 75% N2O (Fig. 1). In all strains, the peak response occurred after 30 min of exposure, and their %MPE ranged between 60% and 80%. All strains also developed tolerance to N2O within 60 to 90 min.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 1. Time course of the effect of 75% nitrous oxide on the tail flick test in four different outbred strains of rats. Open circle indicates control groups, and closed circle indicates nitrous oxide groups. %MPE (mean ± SD). *P < 0.05 versus control.
|
|
Each of the four inbred stains we examined, i.e., the Wistar-Kyoto, the Brown-Norway, the Fischer, and the Lewis, displayed a unique pattern of antinociceptive response to N2O (Fig. 2). The Wistar-Kyoto strain showed a similar pattern as those observed in outbred strains; namely, the peak response occurred after 30 min of exposure, and tolerance developed within 60 min. Although the peak %MPE was similar to that seen in the outbred strains, development of tolerance was more distinct, i.e., %MPE decreased to almost 0% after 60 min, and the variance at each time point was much smaller than that seen in outbred strains. The Brown-Norway strain also showed a similar pattern of antinociceptive response to N2O. However, the peak %MPE at 30 min was much smaller, i.e., approximately 25%.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 2. Time course of the effect of 75% nitrous oxide on the tail flick test in four different inbred strains of rats. Open circle indicates control groups, and closed circle indicates nitrous oxide groups. %MPE (mean ± SD). *P < 0.05 versus control.
|
|
The Fischer strain displayed the greatest antinociceptive response to N2O; %MPE of all tested animals reached 100% after 30 min. Additionally, tolerance did not develop in Fischer rats. Although the variation was relatively large among tested animals, the mean %MPE never decreased to <50% during the 180-min period. However, the Lewis strain showed no antinociceptive response to N2O at any time. In fact, the TFL actually decreased after N2O exposure, suggesting the development of hyperalgesia.
 |
Discussion
|
|---|
To date, several investigators have reported that tolerance develops to the antinociceptive effect of N2O in rats and mice as measured by the TFL response (Table 2). However, one group of investigators has reported that tolerance does not develop to antinociceptive effects of N2O, determined in rats using the same variable (11). Another group has also reported on quantitative differences in the antinociceptive response of various mouse strains to N2O using the abdominal constriction test (12,13). This differential sensitivity to N2O among different mouse strains prompted us to study strain differences in antinociceptive effects of N2O on the tail flick test in rats. We found, in the present study, that while four outbred strains we examined showed similar responses to N2O, four inbred strains showed variable responses to N2O.
View this table:
[in this window]
[in a new window]
|
Table 2. Summary of Previous Reports on Antinociceptive Effects of N2O in Rats and Mice by Using the Tail Flick Test
|
|
In all outbred strains, the peak response occurred after 30 min of N2O exposure, with the %MPE ranging approximately between 60% and 80% (Fig. 1). All outbred strains also developed tolerance to N2O within 60 to 90 minutes. These results are consistent with reports of most other investigators (37). However, each of four inbred stains showed different patterns of antinociceptive response to N2O (Fig. 2). Among them, the Wistar-Kyoto and Brown-Norway strains showed somewhat similar patterns to that observed in outbred strains. In Wistar-Kyoto strain, the peak %MPE was in the same range as those in outbred strains. However, development of tolerance was more distinct; %MPE decreased to almost 0% after 60 minutes, and the SD of %MPE at each time point was much smaller than those observed in outbred strains. The Brown-Norway strain also showed a similar pattern of antinociceptive response to N2O as those in outbred strains. However, the peak %MPE at 30 minutes was much smaller, approximately 25%.
Of particular interest are the Fischer and Lewis strains that displayed the most widely divergent antinociceptive response to N2O. The Fischer strain showed the greatest antinociceptive effect to N2O; %MPE at 30 minutes of all tested animals was 100%. Furthermore, tolerance did not develop during three hours of N2O exposure. The Lewis strain, however, showed no antinociceptive effect to N2O at all. Interestingly, these two strains are known to differ in willingness to self-administer "dependence-producing" drugs, e.g., alcohol and cocaine (1518). Thus far, differences in catecholamine biosynthesis in various regions of the brain (19) and differences in basal levels of opiate peptides and responsiveness to morphine administration (20) have been demonstrated. Notably, the Lewis strain of rats has lower basal levels of opioid peptides than the Fischer strain, and the administration of morphine increases opioid peptide levels in the Fischer strain but not in the Lewis strain.
The most recent studies have shown that N2O produces a release of endogenous opioid peptides in the periaqueductal gray area of the midbrain, which activates noradrenergic descending inhibitory pathways, leading to modulation of nociceptive processing via 2 adrenoceptors in the dorsal horn of the spinal cord (6,21). Although the underlying mechanism for development of tolerance to N2O is not yet well understood, acute depletion of opioid peptides in the central nervous system has been hypothesized to be a possible cause (8). Differences between the Fischer and Lewis strains in antinociceptive response to N2O and in development of tolerance could originate from a disparity in the biochemical and physiological consequences of opioid peptides in the central nervous system in each strain. A possible explanation of our observation is that the lesser amount of endogenous opioid peptides in the periaqueductal gray area of the Lewis strain of rats is insufficient to activate the noradrenergic descending inhibitory pathway. However, the Fischer strain has abundant opioid peptides that produce a powerful antinociceptive effect of N2O and confers resistance to the development of tolerance, because it is not easily depleted.
Our results and results from previous reports by Quock et al. (12,13) imply that investigators should use a specific inbred strain of animal when studying the antinociceptive effects of N2O, because different strains of animals show variable responses to N2O. Also, a less variable genetic stock of inbred strain animals will display fewer phenotypic variations than the more genetically diverse outbred strains, as is evident in the comparison between the Wistar (outbred) and the Wistar-Kyoto (inbred) rat strains. Furthermore, the genetic backgrounds of certain outbred strains might vary significantly among animals from different breeders. Thus, the results from different investigators may not be comparable, even when the results come from the same outbred strain of animals. Furthermore, any time a breeder changes an animal colony, e.g., to prevent spread of disease, it can result in a different phenotype in the outbred strain.
In summary, we have demonstrated that various strains of rats, both outbred and inbred, show different antinociceptive effects of N2O. Our results suggest that investigators should use a specific inbred strain of animal when studying issues related to the antinociceptive effects of N2O.
 |
Acknowledgments
|
|---|
This study was supported by Veterans Administration and National Institute of Health (Grant No. GM 30232).
 |
References
|
|---|
-
Rupreht J, Dworacek B, Bonke B, et al. Tolerance to nitrous oxide decreases in volunteers. Acta Anaesth Scand 1985;29:6358.[Web of Science][Medline]
-
Ramsay DS, Brown AC, Woods SC. Acute tolerance to nitrous oxide in humans. Pain 1992;51:36773.[Web of Science][Medline]
-
Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharm Exp Ther 1977;203:53947.[Abstract/Free Full Text]
-
Berkowitz BA, Finck AD, Hynes MD, Ngai SH. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 1979;51:30912.[Web of Science][Medline]
-
Guo T-Z, Poree L, Golden W, et al. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal
2 adrenergic receptors in the rat. Anesthesiology 1996;85:84652.[Web of Science][Medline]
-
Ohara A, Mashimo T, Zhang P, et al. A comparative study of the antinociceptive action of xenon and nitrous oxide in rats. Anesth Analg 1997;85:9316.[Abstract]
-
Guo T-Z, Davies MF, Kingery WS, et al. Nitrous oxide produces antinociceptive response via
2B and/or 2C adrenoceptor subtypes in mice. Anesthesiology 1999;90:4706.[Web of Science][Medline]
-
Rupreht J, Ukponmwan OE, Dworacek B, et al. Enkephalinase inhibition prevented tolerance to nitrous oxide analgesia in rat. Acta Anaesth Scand 1984;28:61720.[Web of Science][Medline]
-
Mori K, Winters WD. Neural blockade of sleep and anesthesia. Int Anesth Clin 1975;13:67108.[Medline]
-
Stevens JE, Oshima E, Mori K. Effects of nitrous oxide on the epileptogenic property of enflurane in cats. Br J Anaesth 1983;55:14554.[Abstract/Free Full Text]
-
Shingu K, Osawa M, Fukuda K, Mori K. Acute tolerance to the analgesic action of nitrous oxide does not develop in rats. Anesthesiology 1995;62:5024.
-
Quock RM, Mueller JL, Vaughn LK. Strain-dependent differences in responsiveness of mice to nitrous oxide (N2O) antinociception. Brain Res 1993;614:526.[Web of Science][Medline]
-
Quock RM, Mueller JL, Vaughn LK, Belknap JK. Nitrous oxide antinociception in BXD recombinant inbred mouse strains and identification of quantitative trait loci. Brain Res 1996;725:239.[Web of Science][Medline]
-
Hammond DL. Inference of pain and its modulation from simple behaviors. In: Chapman CR, Loeser JD, eds Issues in pain measurement: advances in pain research and therapy. Vol 12. New York:Raven Press, 1989:6991.
-
Li T-K, Lumeng L. Alcohol preference and voluntary alcohol intakes of inbred rat strains and the NIH heterogenous stock of rats. Alcohol Clin Exp Res 1984;8:4856.[Web of Science][Medline]
-
Suzuki T, George FR, Meisch RA. Differential establishment and maintenance of oral ethanol reinforcement behavior in Lewis and Fischer 344 inbred rat strains. Ther 1988;245:16470.
-
Guitart X, Beitner-Johnson D, Marby DW, et al. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system. Synapse 1992;12:24253.[Web of Science][Medline]
-
Guitart X, Kogan JH, Berhow M, et al. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals. Brain Res 1993;611:717.[Web of Science][Medline]
-
Beitner-Johnson D, Guitart X, Nestler EJ. Dopaminergic reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins. Brain Res 1991;561:14750.[Web of Science][Medline]
-
Nylander I, Vlaskovska M, Terenius L. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Res 1995;683:2535.[Web of Science][Medline]
-
Fang F, Guo TZ, Davies MF, Maze M. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Eur J Pharm 1997;336:13741.[Web of Science][Medline]
Accepted for publication September 13, 1999.
This article has been cited by other articles:

|
 |

|
 |
 
S. L. Jinks, E. Carstens, and J. F. Antognini
Nitrous Oxide-Induced Analgesia Does Not Influence Nitrous Oxide's Immobilizing Requirements
Anesth. Analg.,
October 1, 2009;
109(4):
1111 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koyanagi, S. Himukashi, K. Mukaida, T. Shichino, and K. Fukuda
Dopamine D2-Like Receptor in the Nucleus Accumbens Is Involved in the Antinociceptive Effect of Nitrous Oxide
Anesth. Analg.,
June 1, 2008;
106(6):
1904 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Antognini, R. J. Atherley, R. C. Dutton, M. J. Laster, E. I. Eger II, and E. Carstens
The Excitatory and Inhibitory Effects of Nitrous Oxide on Spinal Neuronal Responses to Noxious Stimulation
Anesth. Analg.,
April 1, 2007;
104(4):
829 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vahle-Hinz, O. Detsch, C. Hackner, and E. Kochs
Corresponding minimum alveolar concentrations of isoflurane and isoflurane/nitrous oxide have divergent effects on thalamic nociceptive signalling
Br. J. Anaesth.,
February 1, 2007;
98(2):
228 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Lariviere, M. A. Sattar, and R. Melzack
Inflammation-Susceptible Lewis Rats Show Less Sensitivity Than Resistant Fischer Rats in the Formalin Inflammatory Pain Test and With Repeated Thermal Testing
J Neurophysiol,
May 1, 2006;
95(5):
2889 - 2897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Eicher and J. W. Dailey
Indicators of Acute Pain and Fly Avoidance Behaviors in Holstein Calves Following Tail-docking
J Dairy Sci,
November 1, 2002;
85(11):
2850 - 2858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sawamura, W. S. Kingery, M. F. Davies, G. S. Agashe, J. D. Clark, B. K. Kobilka, T. Hashimoto, and M. Maze
Antinociceptive Action of Nitrous Oxide Is Mediated by Stimulation of Noradrenergic Neurons in the Brainstem and Activation of {alpha}2B Adrenoceptors
J. Neurosci.,
December 15, 2000;
20(24):
9242 - 9251.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|